One patient with a giant tumor progressed despite targeted therapy and immunotherapy

One patient faced a giant abdominal tumor known as mesenteric fibromatosis. This rare condition forms hard tissue in the belly area that often does not respond to standard treatments. Doctors tried a powerful mix of targeted therapy and immunotherapy first. These drugs aim to stop cancer growth or boost the immune system against the disease. Unfortunately, the tumor progressed rapidly despite this aggressive medical approach. The patient then underwent radical resection, which means removing a large part of the organ or tissue. This surgery was followed by careful management from a multidisciplinary team of specialists. They worked together to handle the complex recovery process. The patient faced multiple complications during healing. These included a duodenal fistula, a vaginal fistula, and a ureterorectal fistula. A fistula is an abnormal connection between two body parts that can cause serious issues. Despite these severe setbacks, the patient ultimately recuperated. They kept drainage tubes in place to manage fluid and were able to tolerate oral feeding again. This case report provides an important reference for managing giant mesenteric fibromatosis that continues to progress despite medical therapy. It highlights the challenges doctors face when standard treatments fail and surgery becomes the only option. The story reminds us that even with advanced tools, some diseases remain difficult to control.